Annual report pursuant to Section 13 and 15(d)

Schedule of segment information (Details)

v3.23.1
Schedule of segment information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]    
Net sales $ 7,705,715 $ 6,010,438
Operating income (loss) (1,625,298) (404,336)
Interest income 58,730 70,229
Interest expense 80,199 62,392
Total assets 4,993,892 4,786,441
Property Additions 63,089 161,366
Fixed asset depreciation and amortization 71,257 51,710
Cannabis and Medical Marijuana Segment [Member]    
Segment Reporting Information [Line Items]    
Net sales 37,659 40,764
Operating income (loss) 32,909 26,849
Interest income
Interest expense
Total assets 1,000 900,484
Property Additions
Fixed asset depreciation and amortization
Facility Operations Related [Member]    
Segment Reporting Information [Line Items]    
Net sales 7,670,641 5,969,674
Operating income (loss) (830,098) 95,336
Interest income 5 3
Interest expense 46,321 38,330
Total assets 3,302,931 2,240,047
Property Additions 63,089 160,102
Fixed asset depreciation and amortization 69,176 45,936
Corporate and Eliminations [Member]    
Segment Reporting Information [Line Items]    
Net sales (2,585)
Operating income (loss) (828,109) (526,521)
Interest income 58,725 70,226
Interest expense 33,878 24,062
Total assets 1,689,961 1,645,910
Property Additions 1,264
Fixed asset depreciation and amortization $ 2,081 $ 5,744